The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors

Blood Transfusion

Volumn 12, Issue SUPPL.1, 2014, Pages

  Capittini, Cristina ^a   Bergamaschi, Paola ^a   Sachetto, Sara ^a   Truglio, Mariarosa ^a   Viola, Monica ^a   Marchesi, Andrea ^a   Genovese, Valeria ^a   Romano, Bina ^a   Guarene, Marco ^a   Poma, Rossella ^a   Martinetti, Miryam ^a   Tinelli, Carmine ^a   Salvaneschi, Laura ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

CD34+ cells; Cord blood plasma; HLA G 14bp polymorphism; Liquid nitrogen cryostorage; Soluble HLA G

Indexed keywords

3' UNTRANSLATED REGIONS; ANTIGENS, CD34; BLOOD CELL COUNT; BLOOD DONORS; EXONS; FEMALE; GENOTYPING TECHNIQUES; HEMATOPOIETIC STEM CELLS; HLA-G ANTIGENS; HUMANS; INDEL MUTATION; INFANT, NEWBORN; MALE; MUTAGENESIS, INSERTIONAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; SEQUENCE ANALYSIS, DNA; SOLUBILITY;

EID: 84893949215     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0144-12     Document Type: Article

References (28)

1. Mayani H. Umbilical cord blood: lessons learned and lingering challenges after more than 20 years of basic and clinical research. Arch Med Res 2011; 42: 645-51.
2. Gluckman E, Ruggeri A, Volt F, et al. Milestones in umbilical cord blood transplantation. Br J Haematol 2011; 154: 441-7.
3. Broxmeyer HE. Insights into the biology of cord blood stem/ progenitor cells. Cell Prolif 2011; 44: S55-9.
4. Hunt JS, Langat DL. HLA-G: a human pregnancy-related immunomodulator. Curr Opin Pharmacol 2009; 9: 462-9.
5. Carosella ED, Favier B, Rouas-Freiss N, et al. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008; 111: 4862-70.
6. Menier C, Rouas-Freiss N, Favier B, et al. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 2010; 75: 201-6.
7. González A, Rebmann V, Lemaoult J, et al. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci 2012; 49: 63-84.
8. Lila N, Carpentier A, Amrein C, et al. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355: 2138.
9. Luque J, Torres MI, Aumente MD, et al. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Transpl Immunol 2006; 17: 70-3.
10. Sheshgiri R, Rouas-Freiss N, Rao V, et al. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2008; 27: 522-7.
11. Crispim JC, Duarte RA, Soares CP, et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008; 18: 361-7.
12. Rebmann V, Bartsch D, Wunsch A, et al. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum Immunol 2009; 70: 995-9.
13. Lila N, Amrein C, Guillemain R, et al. Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation. J Heart Lung Transplant 2007; 26: 421-2.
14. Le Maux A, Noël G, Birebent B, et al. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graftversus- host disease and a link with regulatory T cells. Clin Exp Immunol 2008; 152: 50-6.
15. Rousseau P, Le Discorde M, Mouillot G, et al. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003; 64: 1005-10.
16. NetCord-FACT International Standards for Cord Blood Collection, Banking and Release for Administration. Fourth Edition, January 2010.
17. Decreto Ministeriale 03 Marzo 2005. Protocolli per l'accertamento della idoneitàdel donatore di sangue e di emocomponenti. Gazzetta Ufficiale n. 85 del 13 Aprile 2005.
18. Zingsem J, Strasser E, Weisbach V, et al. Cord blood processing with an automated and functionally closed system. Transfusion 2003; 43: 806-13.
19. Gratama JW, Orfao A, Barnett D, et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells, European Working Group on Clinical Cell Analysis. Cytometry 1998; 34: 128-42.
20. Tripathi P, Abbas A, Naik S, Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 2004; 64: 706-10.
21. Broxmeyer HE, Lee MR, Hangoc G, et al. Hematopoietic stem/ progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 2011; 117: 4773-7.
22. Hviid TV, Hylenius S, Rørbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003; 55: 63-79.
23. Gonzalez A, Alegre E, Torres MI, et al. Evaluation of HLA-G5 plasmatic levels during pregnancy and relationship with the 14-bp polymorphism. Am J Reprod Immunol 2010; 64: 367-74.
24. Madureira AB, Eapen M, Locatelli F, et al. Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. Leukemia 2011; 25: 449-54.
25. Rocha V, Gluckman E; Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol 2009; 147: 262-74.
26. Avanzini MA, Bernardo ME, Cometa AM, et al. Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica 2009; 94: 1649-60.
27. Buzzi M, Alviano F, Campioni D, et al. Umbilical cord blood CD34(+) cell-derived progeny produces human leukocyte antigen-G molecules with immuno-modulatory functions. Hum Immunol 2012; 73: 150-5.
28. Creput C, Durrbach A, Charpentier B, et al. HLA-G: immunoregulatory molecule involved in allograft acceptance. Nephrologie 2003; 24: 451-6.